Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 12, Number 9—September 2006

Perspective

Nosocomial Tuberculosis in India

Madhukar Pai*†Comments to Author , Shriprakash Kalantri†, Ashutosh Nath Aggarwal‡, Dick Menzies§, and Henry M. Blumberg¶
Author affiliations: *McGill University, Montreal, Quebec, Canada; †Mahatma Gandhi Institute of Medical Sciences, Sevagram, India; ‡Postgraduate Institute of Medical Education and Research, Chandigarh, India; §McGill University Montreal Chest Institute, Montreal, Quebec, Canada; ¶Emory University School of Medicine, Atlanta, Georgia, USA

Suggested citation for this article

Abstract

Most high-income countries implement tuberculosis (TB) infection control programs to reduce the risk for nosocomial transmission. However, such control programs are not routinely implemented in India, the country that accounts for the largest number of TB cases in the world. Despite the high prevalence of TB in India and the expected high probability of nosocomial transmission, little is known about nosocomial and occupational TB there. The few available studies suggest that nosocomial TB may be a problem. We review the available data on this topic, describe factors that may facilitate nosocomial transmission in Indian healthcare settings, and consider the feasibility and applicability of various recommended infection control interventions in these settings. Finally, we outline the critical information needed to effectively address the problem of nosocomial transmission of TB in India.

The risk that Mycobacterium tuberculosis can be transmitted from patients with active tuberculosis (TB) to other patients and healthcare workers has been recognized for many years (1). The level of risk varies by setting, occupation, patient population, and effectiveness of TB infection control measures (25) but is higher in facilities that manage large numbers of smear-positive TB patients who do not receive rapid diagnosis, isolation, and treatment, particularly in the absence of other infection control measures (25). A hierarchy of control measures, including administrative, engineering, and environmental controls and personal protection measures, has been recommended to reduce nosocomial TB risk (2,3,5,6). These recommended measures are implemented by healthcare facilities in high-income countries (3,6), but given their high cost, few facilities in low-income countries can afford to implement them.

The World Health Organization (WHO) has proposed practical and low-cost interventions to reduce nosocomial transmission in settings where resources are limited (7). These recommendations emphasize prompt diagnosis and rapid treatment of TB rather than expensive technologies, such as isolation rooms and respirators. However, despite the widespread implementation of the directly observed therapy, short course (DOTS) strategy, which is internationally recommended, compliance with these simpler guidelines is generally poor in low-income countries (8).

In general, the primary focus of national TB programs in high-prevalence, low-income countries is to expand basic DOTS services. Typically, nosocomial transmission is ignored, given countries' limited resources, but several factors illustrate that nosocomial TB must be addressed, even in such areas. First, nosocomial transmission is of concern because it affects not only patients who are exposed but also the healthcare workforce, which could adversely affect healthcare services over time (7). Second, transmission of TB can have serious consequences, particularly with multidrug-resistant TB (MDRTB). Several outbreaks in the United States demonstrated the role that hospitals can play as focal points of MDRTB transmission (913), a phenomenon also seen in Europe, South America, South Africa, and Russia (1416). These outbreaks can be explosive and associated with high death rates because hospitalized patients are often immunocompromised (2,9). Therefore, interventions to reduce nosocomial transmission of TB are useful and cost-effective preventive measures to control TB, including MDRTB, particularly in tertiary care settings.

Third, nosocomial TB must be addressed because it can help the healthcare system, particularly the private health sector, improve TB diagnosis and treatment and better align practices with the DOTS strategy. For example, detecting smear-positive TB with microscopy is a key component of the DOTS strategy and an important administrative infection control measure. However, several studies have shown that private practitioners in India tend to underutilize microscopy and rely more on chest radiographs for TB diagnosis (1719). Thus, implementation of infection control measures might motivate the private healthcare sector to adopt the DOTS strategy, and implementation of the DOTS strategy may, in turn, enhance infection control.

Fourth, even though low-income countries have fewer resources, ignoring a potential hazard runs contrary to the principles of protecting human health, the cornerstone of health care in any country. Finally, the problem of controlling TB in hospitals is not a problem with TB alone but reflects a problem with infection control in general, which, if improved, could also prevent other infectious diseases (e.g., severe acute respiratory syndrome and avian influenza) that may be nosocomially transmitted. Thus, TB infection control programs can have secondary benefits. Ultimately, preventing outbreaks and protecting patients and staff are in the interests of healthcare facilities. TB infection control is a good starting point for such efforts.

In this article, we focus on India as a case study and review available studies on nosocomial TB, describe factors that facilitate nosocomial transmission, and consider the feasibility of various recommended TB infection control interventions. Finally, we outline critical questions that need to be studied to effectively address nosocomial TB. Although we focus on India, the issues we raise may be applicable to other high-prevalence, resource-limited countries.

Nosocomial TB in India

India has more TB patients than any other country (20) and accounts for one fifth of the world's incident TB cases (21); the reported incidence in 2003 was 168 per 100,000 (20). Every year, TB develops in nearly 2 million persons in India, and nearly 1 million cases are smear positive; an estimated 40% of the Indian population is latently infected with M. tuberculosis (21). India's Revised National TB Control Programme (RNTCP) now provides access to DOTS for >85% of the population (21). Countrywide coverage is anticipated in 2006 (22). This program is the fastest expanding DOTS program in the world and the largest in the world in terms of patients receiving initial treatment (21). Outside of the RNTCP, India has a large private health sector that is actively involved in providing TB care (23,24); almost half of patients with TB in India initially seek care from the private sector (22). Thus, because Indian healthcare workers see large numbers of TB patients and because large numbers of TB patients are hospitalized (25), the risk for nosocomial exposure is substantial.

Despite the prevalence of TB in India and the expected high probability of nosocomial transmission, little is known about nosocomial TB. In fact, until 2004, no studies on nosocomial TB in India had been published. Table 1 summarizes the results of recent studies on TB among healthcare workers from 3 large tertiary hospitals (2630). These studies provide some data on the incidence of active TB (28,29), prevalence of latent TB infection (26), risk factors for active TB (30), and annual risk for latent TB infection among healthcare workers (27). In addition, another recent study documented person-to-person transmission of TB among hospitalized patients (31).

At a rural medical school hospital in Sevagram, Pai et al. performed the tuberculin skin test (TST) and a whole-blood interferon-γ release assay (IGRA) for 726 healthcare workers (26); 50% were positive by either TST or IGRA. Nearly 70% of the participants reported direct contact with sputum smear–positive TB patients. Exposure was particularly high among physicians in training, attending physicians, and nurses. Increasing age and duration of employment were risk factors for latent TB infection. Nurses, nursing students, orderlies, and laboratory staff had higher prevalence of latent infection (26). A repeat survey of 216 medical and nursing students in this cohort enabled estimation of the annual risk for latent infection by using TST and IGRA (27). When both tests were used, the annual risk for latent TB infection was estimated to be 5% (27). The estimated community-based annual risk for infection in India is 1.5% (32), so the excess risk of 3.5% may be attributable to nosocomial exposure.

At a tertiary care hospital in Chandigarh, Rao et al. estimated the incidence of active TB among resident physicians (28). Among residents already working in the hospital, TB developed in 9 (2%) of 470, for an incidence of 11.2 new cases per 1,000 person-years of exposure. Extrapulmonary disease developed in two thirds of the residents. Overall, this study showed a high rate of TB (predominantly extrapulmonary) among those who worked in medical subspecialties. However, most cases were identified by using clinical criteria, and few were bacteriologically confirmed.

In a retrospective review of healthcare workers who underwent anti-TB treatment in a tertiary care hospital in Vellore, Gopinath et al. identified 125 healthcare workers who had been treated for active TB between 1992 and 2001 (29). The annual incidence of pulmonary TB was 0.35–1.80 per 1,000 persons during this period. The annual incidence of extrapulmonary TB was 0.34–1.57 per 1,000. These rates may have been underestimated because only healthcare workers who underwent TB treatment were counted. In this hospital, a case-control study showed that low body mass index and employment in medical wards were risk factors for TB disease among healthcare workers (30).

In a molecular epidemiologic study at a TB hospital in Delhi, Bhanu et al. performed DNA fingerprinting on 83 M. tuberculosis isolates from patients in 2 adjacent wards (31). Of these 83 isolates, 8 strains were grouped into 3 clusters (identical fingerprints) by using IS6110 restriction fragment length polymorphism and spoligotyping analyses. Within each cluster, epidemiologic data showed overlapping hospitalization periods, which raises the possibility of nosocomial transmission (31).

In summary, these studies suggest that nosocomial transmission of TB is a problem in India. The prevalence of latent TB infection and annual risk for TB infection appears to be high even among young healthcare workers. For example, in a hypothetical Indian hospital with 1,000 workers, ≈500 (50%) will likely have latent infection, and ≈25 (5%) of uninfected workers will be newly infected each year. The rate of active disease appears to be exceedingly high in subgroups such as interns, residents, and nurses. The incidences of TB disease and infection are higher than the national averages, which suggests an increased risk for acquiring TB in the hospital setting. For example, the estimated incidence of TB among residents was 10-fold higher than the incidence for the country (28).

The predominance of extrapulmonary (mostly pleural) disease among healthcare workers may indicate progression to disease from newly acquired primary infection rather than reactivation of latent TB. Molecular epidemiologic studies suggest that pleural TB is different from other forms of extrapulmonary TB and is associated with the highest fingerprint clustering rate of all forms of TB, which suggests that pleural TB may be an early manifestation of recent infection (33). Lastly, although this assumption is based on limited data, nosocomial transmission of TB among hospitalized patients may occur in urban hospitals.

Factors That May Facilitate Nosocomial Transmission

Several factors may facilitate nosocomial transmission in Indian hospitals, although their relative importance in facilitating transmission is unknown (Table 2). The overwhelming number of TB patients and repeated exposures to smear-positive TB patients are likely to be critical factors. The RNTCP alone starts treatment for >100,000 patients every month (21), and thousands more are managed in the private sector (19,2224). Repeated exposure of trainees is particularly worrisome, given the lack of TB infection control measures at most healthcare facilities. In India, students begin the undergraduate medical program at the age of 17 or 18 years. After an initial classroom-based program in basic sciences, they begin their clinical rotations during years 2 and 3. During this phase of their training, stress is placed on physical examination. Evaluation of the respiratory system, for example, is invariably included in licensure examinations. Because patients with cavitary TB are likely to exhibit signs during a lung exam, TB patients are considered excellent teaching material. Trainees spend considerable time eliciting physical signs in such patients, which results in repeated exposure to patients with infectious TB during trainees' first clinical rotations. This fact may explain the high incidence of infection among them (27).

Delays in diagnosis and initiation of treatment and failure to separate or isolate patients with smear-positive TB from other patients also contribute to transmission risk. Previous studies in India have shown that diagnostic delays are common, and private practitioners, in particular, tend to underuse sputum microscopy, thereby increasing the probability of missing infectious TB patients (17,19,34). Unnecessary or prolonged hospitalization of TB patients who could have been treated on an ambulatory basis might also contribute to high exposure levels in hospitals. A survey of TB hospitals in India showed that nearly 1 million patients sought treatment in 1999. Approximately 77% of these patients were reported to have undergone sputum examination, and one third of all patients had a diagnosis of TB (25). Approximately one third of the hospitals admitted every sputum smear–positive TB patient encountered at their institution.

Several factors might prolong infectiousness of TB patients and thereby facilitate nosocomial transmission. Poor adherence to treatment, lack of continuous drug supply, use of suboptimal treatment regimens, lack of adequate treatment support (e.g., direct observation of therapy [DOT]), and insufficient treatment duration have been reported, particularly in the private sector (18,19,24,25,35,36).

Few hospitals in India have established infection control procedures. Hospitals, especially publicly owned facilities, tend to be crowded, poorly ventilated, and have limited or no facilities for respiratory isolation. Most respiratory care procedures (including sputum collection) are routinely carried out in a general ward setting, rather than in respiratory isolation rooms. Further, few of these hospitals offer routine screening programs to detect and treat TB among healthcare workers.

Previous surveys have identified gaps in knowledge and awareness about TB in healthcare workers in India (18,19,24,36,37). A survey of 213 nurses in 2 hospitals in Delhi showed that only 67% reported M. tuberculosis as the causative organism, and only 22% reported sputum microscopy as the most appropriate way to diagnose TB (37). In another survey, only 12% of 204 private practitioners in Delhi reported ordering sputum smears for a patient with suspected TB. For treating TB, 187 physicians used 102 different regimens (18). Other surveys have reported similar findings in India (17,19,24,35,36). Finally, healthcare workers may believe that that they cannot avoid nosocomial infection, which results in resigned acceptance on their part. Since nearly half the Indian population is infected, healthcare workers do not view latent TB infection as a problem. Hence, latent infection is rarely treated, even in high-risk groups such as household contacts and HIV-infected patients (38,39).

Implementing TB Infection Control in India

Effective TB infection control in healthcare settings depends on early identification, isolating infected persons, and rapidly and effectively treating persons with TB (2,4,5). In all healthcare settings, a basic TB infection control program should be implemented, as recommended by WHO and other agencies (25,7). WHO also recommends developing an infection control plan, educating healthcare workers and patients, improving sputum collection practices, performing triage and evaluation of suspected TB patients in outpatient settings, and reducing exposure in the laboratory (7). In the United States, administrative controls (early detection, isolation, and treatment of patients with TB) have been the most effective components of TB infection control programs (9).

In India, of all the recommended interventions, implementing administrative controls is likely to be the most feasible and effective strategy. Controls include early detection of patients with infectious TB, isolating or at least segregating those with infectious pulmonary TB from other patients, and rapidly initiating anti-TB treatment, supported by measures to improve adherence (e.g., DOT).

Implementing many of the recommended engineering controls is not feasible in most healthcare facilities because of the high costs of such measures (e.g., negative-pressure isolation rooms). However, separation or segregation of smear-positive TB patients in private or semiprivate rooms or wards with simple mechanical exhaust ventilation (e.g., window fans) could be feasible in some settings, particularly in the private sector and well-funded public hospitals. These measures have been shown to be useful in terminating an outbreak of nosocomial tuberculosis (9). This intervention is particularly necessary at centers that manage patients with MDRTB; at such centers, patients with infectious TB must not be admitted to the same wards as patients with HIV infection.

Personal respiratory protection measures (e.g., N95 respirators) are probably not feasible because of the high cost. Respirators may be relatively costly to implement and of limited effectiveness in high-incidence, resource-limited settings (40). The use of respirators may have a role in hospitals that manage MDRTB, but more successful and affordable measures include improving natural ventilation through open windows and sunlight. The efficacy of UV germicidal lights is being evaluated in other low-income countries, and results of such studies are needed to determine their value in reducing nosocomial transmission. In developing TB infection control programs, crucial issues are educating healthcare workers about nosocomial TB and measures that can help prevent such transmission, educating patients on cough procedures, and using simple surgical masks on patients with infectious TB (especially if they are not segregated) who are coughing.

Periodic testing of healthcare workers for latent TB and treating those with latent infections who are at high risk for progression to active TB might be feasible in selected settings, particularly among trainees and junior staff (who seem to be disproportionately affected). Screening for latent TB infection with newer, blood-based IGRAs may not be feasible in most settings at this time. Although IGRAs have some advantages over TST, including increased specificity and the ability to discriminate between infection with M. tuberculosis and M. bovis BCG, they have limited applicability in many resource-limited settings because of the high costs and the need for laboratory infrastructure (26,41). However, new data suggest that IGRAs hold promise for serial testing of healthcare workers and can overcome some of the limitations of serial tuberculin testing (27). A recent study from India showed that in a setting with intensive nosocomial exposure, healthcare workers had strong interferon-γ responses that persistently stayed elevated even after treatment for latent infection (42). Persistence of infection or reexposure might account for this phenomenon.

Evaluation of symptomatic healthcare workers for active TB is feasible and should be implemented routinely. In addition to the above measures, hospitals should make every effort to treat TB patients on an ambulatory basis (25). If hospitalization is required, every effort should be made to segregate potentially infectious patients from immunocompromised patients, rapidly diagnose and initiate treatment, and discharge patients promptly with DOT on an outpatient basis.

Lastly, efforts should be made to improve the quality of TB care in the private sector through better coordination between the RNTCP and the private sector (22). By improving TB diagnosis and treatment practices, smear-positive TB patients are more likely to receive rapid diagnosis and treatment, thereby directly and indirectly reducing the overall transmission in the community and in the nosocomial setting. Such public-private partnerships are currently ongoing in India (22), and these programs could address the issue of nosocomial TB.

Who should design and implement TB infection control programs in India? This is a complicated issue because of the variability of healthcare systems in India (e.g., public, private, corporate, nongovernmental, and alternative medical systems). Further, the private sector in India is dominant, diverse, and largely unregulated (22). Although a few hospitals have received quality certifications (e.g., ISO 9000), no pressure is on healthcare facilities to get accredited; in fact, India has no national accrediting body. Also, a large proportion of Indians pay for health care with personal funds rather than health insurance.

Given these problems, we cannot envision a simple approach to implementing infection control programs in India. While technical guidance should come from international agencies such as WHO and the International Union Against Tuberculosis and Lung Disease, these guidelines need to be adapted to the Indian context by RNTCP. Ultimately, implementing adequate infection control measures is the responsibility of each healthcare facility. RNTCP may not have the regulatory authority to enforce implementation; however, by partnering with the private sector, RNTCP can improve the quality of case detection and treatment provided in the private sector, which can, by itself, improve infection control.

Call for Research and Action

Despite India's long and distinguished history of TB research, nosocomial TB has in large part not been addressed by researchers, at least until recently. Although a few studies have been published (2631), many more are needed, as summarized in Table 3. A first step is to determine the prevalence of TB among healthcare workers and to evaluate risk factors for nosocomial transmission. In addition, we must assess the availability of resources in India to implement TB infection control measures and to assess what additional resources are needed in areas that have little or no TB infection control programs. India is a vast country with substantial regional variability in resources and expertise. Some healthcare facilities (e.g., private hospitals and medical schools) may have implemented control measures or may have the resources and skills needed to establish effective infection control programs.

After assessing the disease prevalence, risk factors, and resources, India must implement effective strategies to reduce nosocomial transmission. To intervene, we will need to know what interventions will and will not work in India. Trials are therefore needed to evaluate relatively simple, feasible interventions and their effectiveness in reducing nosocomial risk. The lessons learned in such trials will be applicable in other resource-limited settings.

In conclusion, healthcare workers are essential in the fight against TB, and their health needs to be protected. India, with its vast human and intellectual capital, nearly countrywide DOTS coverage, and a large, well-funded, successful national TB control program, is well placed to tackle this problem and set an example for other high-prevalence countries.

Drs Pai and Menzies are supported by the Canadian Institutes of Health Research (CIHR), Canada.

Dr Pai is assistant professor of epidemiology at McGill University, Montreal, Canada. His research interests include global health, epidemiology of tuberculosis, nosocomial transmission, and evaluation of novel diagnostic and prognostic tools for global tuberculosis control.

Acknowledgment

We thank Puneet K. Dewan for helpful comments on an earlier draft of this manuscript and Edward Nardell for helpful discussions.

References

  1. Sepkowitz KA. Tuberculosis and the health care worker: a historical perspective. Ann Intern Med. 1994;120:719.PubMed
  2. Blumberg HM. Tuberculosis infection control in healthcare settings. In: Lautenbach E, Woeltje K, editors. Practical handbook for healthcare epidemiologists. New Jersey: Slack Incorporated; 2004. p. 259–73.
  3. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54:1141.PubMed
  4. Menzies D, Fanning A, Yuan L, Fitzgerald M. Tuberculosis among health care workers. N Engl J Med. 1995;332:928. DOIPubMed
  5. Blumberg HM. Tuberculosis infection control. In: Reichman LB, Hershield E, editors. Tuberculosis: a comprehensive international approach. 2nd ed. New York: Marcel-Dekker, Inc; 2000. p. 609–44.
  6. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 1994. Atlanta, GA: The Centers; 1994.
  7. World Health Organization. Guidelines for the prevention of tuberculosis in health care facilities in resource-limited settings. Geneva: The Organization; 1999.
  8. Jones-Lopez EC, Ellner JJ. Tuberculosis infection among HCWs. Int J Tuberc Lung Dis. 2005;9:591.PubMed
  9. Blumberg HM, Watkins DL, Berschling JD, Antle A, Moore P, White N, Preventing the nosocomial transmission of tuberculosis. Ann Intern Med. 1995;122:65863.PubMed
  10. Beck-Sague C, Dooley SW, Hutton MD, Otten J, Breeden A, Crawford JT, Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA. 1992;268:12806. DOIPubMed
  11. Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams J, Sordillo EM, An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326:151421. DOIPubMed
  12. Jereb JA, Klevens RM, Privett TD, Smith PJ, Crawford JT, Sharp VL, Tuberculosis in health care workers at a hospital with an outbreak of multidrug-resistant Mycobacterium tuberculosis. Arch Intern Med. 1995;155:8549. DOIPubMed
  13. Zaza S, Blumberg HM, Beck-Sague C, Haas WH, Woodley CL, Pineda M, Nosocomial transmission of Mycobacterium tuberculosis: role of health care workers in outbreak propagation. J Infect Dis. 1995;172:15429. DOIPubMed
  14. Moro ML, Gori A, Errante I, Infuso A, Franzetti F, Sodano L, An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. Italian Multidrug-Resistant Tuberculosis Outbreak Study Group. AIDS. 1998;12:1095102. DOIPubMed
  15. Ritacco V, Di Lonardo M, Reniero A, Ambroggi M, Barrera L, Dambrosi A, Nosocomial spread of human immunodeficiency virus–related multidrug-resistant tuberculosis in Buenos Aires. J Infect Dis. 1997;176:63742. DOIPubMed
  16. Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, Zakharova S, Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA. 2005;293:272631. DOIPubMed
  17. Prasad R, Nautiyal RG, Mukherji PK, Jain A, Singh K, Ahuja RC. Diagnostic evaluation of pulmonary tuberculosis: what do doctors of modern medicine do in India? Int J Tuberc Lung Dis. 2003;7:527.PubMed
  18. Singla N, Sharma PP, Singla R, Jain RC. Survey of knowledge, attitudes and practices for tuberculosis among general practitioners in Delhi, India. Int J Tuberc Lung Dis. 1998;2:3849.PubMed
  19. Uplekar M, Juvekar S, Morankar S, Rangan S, Nunn P. Tuberculosis patients and practitioners in private clinics in India. Int J Tuberc Lung Dis. 1998;2:3249.PubMed
  20. World Health Organization. Global tuberculosis control. Surveillance, planning, financing. WHO Report 2005. Geneva: The Organization; 2005.
  21. Central TB. Division, Directorate General of Health Services. TB India 2005. RNTCP Status report. New Delhi, India: Ministry of Health and Family Welfare; 2005.
  22. Dewan PK, Lal SS, Lonnroth K, Wares F, Uplekar M, Sahu S, Improving tuberculosis control through public-private collaboration in India: literature review. BMJ. 2006;332:5748. DOIPubMed
  23. Rangan S. The public-private mix in India's Revised National Tuberculosis Control Programme–an update. J Indian Med Assoc. 2003;101:1613.PubMed
  24. Uplekar MW, Rangan S. Private doctors and tuberculosis control in India. Tuber Lung Dis. 1993;74:3327. DOIPubMed
  25. Singh AA, Frieden TR, Khatri GR, Garg R. A survey of tuberculosis hospitals in India. Int J Tuberc Lung Dis. 2004;8:12559.PubMed
  26. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA. 2005;293:274655. DOIPubMed
  27. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri SP, Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med. 2006;174:34955. DOIPubMed
  28. Rao KG, Aggarwal AN, Behera D. Tuberculosis among physicians in training. Int J Tuberc Lung Dis. 2004;8:13924.PubMed
  29. Gopinath KG, Siddique S, Kirubakaran H, Shanmugam A, Mathai E, Chandy GM. Tuberculosis among healthcare workers in a tertiary-care hospital in South India. J Hosp Infect. 2004;57:33942. DOIPubMed
  30. Mathew A, David T, Kuruvilla PJ, Jesudasan M, Thomas K. Risk factors for tuberculosis among health care workers in southern India. Presented at the 43rd Annual Meeting of the Infectious Diseases Society of America (IDSA); San Francisco; 2005.
  31. Bhanu NV, Banavalikar JN, Kapoor SK, Seth P. Suspected small-scale interpersonal transmission of Mycobacterium tuberculosis in wards of an urban hospital in Delhi, India. Am J Trop Med Hyg. 2004;70:52731.PubMed
  32. Chadha VK, Kumar P, Jagannatha PS, Vaidyanathan PS, Unnikrishnan KP. Average annual risk of tuberculous infection in India. Int J Tuberc Lung Dis. 2005;9:1168.PubMed
  33. Ong A, Creasman J, Hopewell PC, Gonzalez LC, Wong M, Jasmer RM, A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco. Clin Infect Dis. 2004;38:2531. DOIPubMed
  34. Rajeswari R, Chandrasekaran V, Suhadev M, Sivasubramaniam S, Sudha G, Renu G. Factors associated with patient and health system delays in the diagnosis of tuberculosis in South India. Int J Tuberc Lung Dis. 2002;6:78995.PubMed
  35. Prasad R, Nautiyal RG, Mukherji PK, Jain A, Singh K, Ahuja RC. Treatment of new pulmonary tuberculosis patients: what do allopathic doctors do in India? Int J Tuberc Lung Dis. 2002;6:895902.PubMed
  36. Uplekar MW, Shepard DS. Treatment of tuberculosis by private general practitioners in India. Tubercle. 1991;72:28490. DOIPubMed
  37. Singla N, Sharma PP, Jain RC. Awareness about tuberculosis among nurses working in a tuberculosis hospital and in a general hospital in Delhi, India. Int J Tuberc Lung Dis. 1998;2:100510.PubMed
  38. Sheikh K, Rangan S, Deshmukh D, Dholakia Y, Porter J. Urban private practitioners: potential partners in the care of patients with HIV/AIDS. Natl Med J India. 2005;18:326.PubMed
  39. Padmapriyadarsini C, Swaminathan S. Preventive therapy for tuberculosis in HIV infected individuals. Indian J Med Res. 2005;121:41523.PubMed
  40. Biscotto CR, Pedroso ER, Starling CE, Roth VR. Evaluation of N95 respirator use as a tuberculosis control measure in a resource-limited setting. Int J Tuberc Lung Dis. 2005;9:5459.PubMed
  41. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004;4:76176. DOIPubMed
  42. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Dheda K, Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol. 2006;1:7. DOIPubMed

Tables

Suggested citation for this article: Pai M, Kalantri S, Aggarwal AN, Menzies D, Blumberg HM. Nosocomial tuberculosis in India. Emerg Infect Dis [serial on the Internet]. 2006 Sep [date cited]. http://dx.doi.org/10.3201/eid1209.051663

DOI: 10.3201/eid1209.051663

Top of Page

Table of Contents – Volume 12, Number 9—September 2006

Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Address for correspondence:Madhukar Pai, Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 1020 Pine Ave West, Montreal, Quebec, Canada H3A 1A2





characters(s) remaining.

Comment submitted successfully, thank you for your feedback.

Comments to the EID Editors

Please contact the EID Editors via our Contact Form.

 

Past Issues

Select a Past Issue:

World Malaria Day - April 25, 2014 - Invest in the future, defeat malaria

20th Anniversary - National Infant Immunization Week - Immunization. Power to Protect.

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO